Developer docs
API playgroundTry for free, no card

Search company profiles

RC Capital

Full company profile

uuid0000rh4

Namestring
RC Capital
Legal namestring
RC Capital (River Cities Capital Funds)
Websiteurl
rccf.com
Company typeenum
Private
Founded yearint
1994
Descriptiontext

RC Capital (legally River Cities Capital Funds) is a Cincinnati-based healthcare growth equity firm founded in 1994 that invests in commercial-stage companies at the lower end of the US middle market. The firm organizes its investing around three pillars — Medical Devices, Healthcare Services, and Healthcare IT — and positions itself as a sector-specialist operating partner, deploying both financial and human capital alongside portfolio management teams. RC Capital currently manages its sixth fund (Fund VI), maintains a regional office in Raleigh, NC, and runs an 11-50 person team structured into MedTech and Healthcare Services groups under four Managing Partners (Daniel Fleming, J. Carter McNabb, Robert Heimann, and Rurik "Rik" Vandevenne).

The firm does not develop technology products in the conventional sense. Its operating model centers on direct sourcing of proprietary deal flow, majority or significant equity investments in healthcare companies, and value creation through board involvement, executive network access, and operational guidance. Recent disclosed activity includes the $15 million growth financing for Catalyst OrthoScience (October 2025), a growth investment in Captive Radiology (May 2026), a 2022 growth recapitalization of Cognitive Research Corporation (CRC), and an investment in Standard Bariatrics that was realized through its acquisition by Teleflex. The firm also curates ecosystem touchpoints such as the annual Healthcare Operator Summit and the proprietary Senior Management Compensation Survey.

RC Capital's revenue model follows a standard US private equity structure: limited partners commit capital to successive flagship funds, the firm earns management fees on committed or invested capital, and realizes carried interest upon profitable exits. Specific fee rates, fund sizes, AUM, and LPs are not publicly disclosed. The firm's "customers" in effect are two-sided: portfolio companies (which receive capital and operational support) and institutional LPs (family offices, endowments, foundations) that subscribe to the funds. This two-sided structure underwrites the firm's revenue durability and exit-driven economics.

Short descriptiontext

RC Capital is a Cincinnati-based healthcare growth equity firm founded in 1994 investing in lower middle market Medical Devices, Healthcare Services, and Healthcare IT companies, currently deploying its sixth fund across two offices.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCincinnati, United States
HQ citystring
Cincinnati
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare growth equity, middle market private equity, medical device investing, healthcare services investing, healthcare IT investing
Industry2 codes
PRIMARYFSANACAD
Business Services (B2B) Growth Equity
SECONDARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Growth Equity (Private Equity)
Revenue model1 record
1Portfolio Company Investment Returns
TypeManaged Services
Description

RC Capital generates returns through equity investments in healthcare companies, typically acquiring majority or significant stakes, and realizing returns through portfolio company exits via M&A or recapitalizations. The firm participates as a trusted partner, investing human capital alongside financial capital to drive transformational growth.

rccf.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Institutional investment management services for Limited Partners
ModelOtherBilling cadenceAnnual
Notes

PE fund structure with management fees and carried interest - not publicly disclosed

rccf.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

RC Capital is a healthcare-focused growth equity firm that invests in lower middle market companies across Medical Devices, Healthcare Services, and Healthcare IT. The firm acquires majority or significant equity stakes, then partners with management to drive transformational growth through operational support, strategic guidance, and network access, ultimately realizing returns through M&A exits or recapitalizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Successful exit of Standard Bariatrics to Teleflex
+3 more records
Product overview1 text field

RC Capital is a healthcare-focused growth equity firm, not a product company. The firm does not offer standalone products or services in the traditional sense. Instead, RC Capital builds high-potential healthcare companies by leveraging the interplay of three investment segments: Medical Devices, Healthcare Services, and Healthcare IT. The firm's portfolio includes companies such as SPR Therapeutics, Captive Radiology, Cognitive Research Corporation (CRC), ModifyHealth, Standard Bariatrics, Aligned Cardiovascular Partners, Mindpath Health, FlexCare, and others spanning diagnostic imaging, surgical devices, CNS-focused contract research, food-as-medicine platforms, behavioral health, and healthcare technology solutions.

Product and service3 records
1Medical Devices Growth Equity Investments
CategoryMedical Devices Growth Equity
Description

Growth equity capital and operational partnership for commercial-stage and emerging medical device companies, including surgical devices, diagnostics, and therapeutic technologies. Portfolio examples include Standard Bariatrics and Catalyst OrthoScience.

2Healthcare Services Growth Equity Investments
CategoryHealthcare Services Growth Equity
Description

Growth equity capital and value-creation partnership for healthcare services businesses including diagnostic imaging, contract research, cardiovascular care, and food-as-medicine platforms. Portfolio examples include Captive Radiology, Cognitive Research Corporation (CRC), and Aligned Cardiovascular Partners.

3Healthcare IT Growth Equity Investments
CategoryHealthcare IT Growth Equity
Description

Growth equity capital and strategic partnership for healthcare information technology companies serving clinicians, payers, and patients, including tech-enabled care delivery, remote patient monitoring, and EMR-connected platforms. Portfolio example includes ModifyHealth.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

L.E.K. Consulting's Stuart Jackson and IIya Trakhtenberg presented insights from their book 'Predictable Winners' at the 2025 Healthcare Operator Summit.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Jeet Guram from McKinsey led a session on 'State of the Healthcare Market and PE Value Creation' at the 2025 Operator Summit.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Ben Port and Jason Porter from Baird's Global Healthcare Investment Banking Group led discussions on M&A environment in healthcare at the 2025 Operator Summit.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Peter Harrison from Morgan Stanley led discussions on M&A and capital markets environment in MedTech at the 2025 Operator Summit.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sanchit Mullick and Andrew Bravo from Reveal HealthTech led a session on leveraging AI in portfolio company value creation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Michael Haugen from ghSMART presented the ghSMART A Method for hiring top talent at the 2025 Operator Summit dinner.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Webster Equity Partners is a healthcare-focused growth and buyout firm investing in the lower middle market, with similar deal-size profile and sector emphasis on healthcare services and products — directly comparable to RC Capital's strategy.

TypeDirect peer
Description

Thyra Capital is a healthcare-focused private equity firm targeting growth-stage and lower middle market healthcare companies, overlapping closely with RC Capital's Medical Devices, Healthcare Services, and HCIT focus areas.

TypeDirect peer
Description

Shore Capital Partners is a lower middle market private equity firm with a dedicated healthcare practice, investing equity in growth-stage healthcare companies — a close strategic and structural analog to RC Capital.

TypeBroad incumbent
Description

WCAS is a large, established healthcare-focused private equity firm with a much broader AUM base but a comparable healthcare services and HCIT investment lens, making it an incumbent reference point for sector-specialist PE.

TypeBroad incumbent
Description

New Mountain Capital is a large investment firm with a strong healthcare services and healthcare IT franchise, representing a larger incumbent that competes for many of the same assets RC Capital targets.

TypeBroad incumbent
Description

Genstar Capital is a diversified PE firm with a meaningful healthcare growth and buyout practice, including medical device and services investing — a relevant broader incumbent in the healthcare lower middle and middle market.

TypeBroad incumbent
Description

TPG operates large healthcare-dedicated funds (TPG Healthcare) investing across services, devices, and life sciences — an incumbent mega-fund whose activities increasingly extend into RC Capital's addressable market.

TypeDirect peer
Description

Health Velocity Capital is a healthcare-focused growth equity and venture firm investing across healthcare services, HCIT, and medical devices, making it a closely comparable growth-stage specialist peer.

9AlerisLife (legacy Watermark Capital / Cressey & Company)
TypeDirect peer
Description

Cressey & Company is a healthcare-focused PE firm based in Chicago investing in growth-stage healthcare services and technology businesses, similar in strategy and scale to RC Capital.

TypeDirect peer
Description

Avista Capital Partners is a healthcare-focused private equity firm investing across healthcare services, pharmaceuticals, and medical devices — a closely comparable sector-specialist peer for benchmarking strategy and portfolio overlap.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles22 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment117 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RC Capital

Healthcare Growth Equity (Private Equity)rccf.com

RC Capital is a Cincinnati-based healthcare growth equity firm founded in 1994 investing in lower middle market Medical Devices, Healthcare Services, and Healthcare IT companies, currently deploying its sixth fund across two offices.

What RC Capital does

RC Capital (legally River Cities Capital Funds) is a Cincinnati-based healthcare growth equity firm founded in 1994 that invests in commercial-stage companies at the lower end of the US middle market. The firm organizes its investing around three pillars — Medical Devices, Healthcare Services, and Healthcare IT — and positions itself as a sector-specialist operating partner, deploying both financial and human capital alongside portfolio management teams. RC Capital currently manages its sixth fund (Fund VI), maintains a regional office in Raleigh, NC, and runs an 11-50 person team structured into MedTech and Healthcare Services groups under four Managing Partners (Daniel Fleming, J. Carter McNabb, Robert Heimann, and Rurik "Rik" Vandevenne).

The firm does not develop technology products in the conventional sense. Its operating model centers on direct sourcing of proprietary deal flow, majority or significant equity investments in healthcare companies, and value creation through board involvement, executive network access, and operational guidance. Recent disclosed activity includes the $15 million growth financing for Catalyst OrthoScience (October 2025), a growth investment in Captive Radiology (May 2026), a 2022 growth recapitalization of Cognitive Research Corporation (CRC), and an investment in Standard Bariatrics that was realized through its acquisition by Teleflex. The firm also curates ecosystem touchpoints such as the annual Healthcare Operator Summit and the proprietary Senior Management Compensation Survey.

RC Capital's revenue model follows a standard US private equity structure: limited partners commit capital to successive flagship funds, the firm earns management fees on committed or invested capital, and realizes carried interest upon profitable exits. Specific fee rates, fund sizes, AUM, and LPs are not publicly disclosed. The firm's "customers" in effect are two-sided: portfolio companies (which receive capital and operational support) and institutional LPs (family offices, endowments, foundations) that subscribe to the funds. This two-sided structure underwrites the firm's revenue durability and exit-driven economics.

RC Capital firmographics

Firmographics
Name
RC Capital
Legal name
RC Capital (River Cities Capital Funds)
Website
https://rccf.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
51–100 employees
Short description
RC Capital is a Cincinnati-based healthcare growth equity firm founded in 1994 investing in lower middle market Medical Devices, Healthcare Services, and Healthcare IT companies, currently deploying its sixth fund across two offices.
Ownership category
akta.pro rank

RC Capital industry classification

Industry
Product category
Healthcare Growth Equity (Private Equity)
NAICS
Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANACAD
Business Services (B2B) Growth Equity
SECONDARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)

Keywords

  • Healthcare growth equity
  • Middle market private equity
  • Medical device investing
  • Healthcare services investing
  • Healthcare IT investing

Where RC Capital is headquartered

Location

Headquarters

HQ city
Cincinnati
HQ country
United States
HQ region
North America

Offices2 records

Markets served

RC Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Portfolio Company Investment Returns: RC Capital generates returns through equity investments in healthcare companies, typically acquiring majority or significant stakes, and realizing returns through portfolio company exits via M&A or recapitalizations. The firm participates as a trusted partner, investing human capital alongside financial capital to drive transformational growth.

Pricing tiers

ModelBillingPrice
OtherAnnualInstitutional investment management services for Limited Partners

Distribution channels1 record

Marketing channels4 records

RC Capital product offering

Product offering

Core offering

RC Capital is a healthcare-focused growth equity firm that invests in lower middle market companies across Medical Devices, Healthcare Services, and Healthcare IT. The firm acquires majority or significant equity stakes, then partners with management to drive transformational growth through operational support, strategic guidance, and network access, ultimately realizing returns through M&A exits or recapitalizations.

Product overview

RC Capital is a healthcare-focused growth equity firm, not a product company. The firm does not offer standalone products or services in the traditional sense. Instead, RC Capital builds high-potential healthcare companies by leveraging the interplay of three investment segments: Medical Devices, Healthcare Services, and Healthcare IT. The firm's portfolio includes companies such as SPR Therapeutics, Captive Radiology, Cognitive Research Corporation (CRC), ModifyHealth, Standard Bariatrics, Aligned Cardiovascular Partners, Mindpath Health, FlexCare, and others spanning diagnostic imaging, surgical devices, CNS-focused contract research, food-as-medicine platforms, behavioral health, and healthcare technology solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Devices Growth Equity Investments Growth equity capital and operational partnership for commercial-stage and emerging medical device companies, including surgical devices, diagnostics, and therapeutic technologies. Portfolio examples include Standard Bariatrics and Catalyst OrthoScience.
  • Healthcare Services Growth Equity Investments Growth equity capital and value-creation partnership for healthcare services businesses including diagnostic imaging, contract research, cardiovascular care, and food-as-medicine platforms. Portfolio examples include Captive Radiology, Cognitive Research Corporation (CRC), and Aligned Cardiovascular Partners.
  • Healthcare IT Growth Equity Investments Growth equity capital and strategic partnership for healthcare information technology companies serving clinicians, payers, and patients, including tech-enabled care delivery, remote patient monitoring, and EMR-connected platforms. Portfolio example includes ModifyHealth.

Quantifiable outcome

  • Successful exit of Standard Bariatrics to Teleflex
  • +3 more outcomes

Companies that use RC Capital

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

RC Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

RC Capital partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor.

  • L.E.K. ConsultingminorStrategic or Co-development PartnerL.E.K. Consulting's Stuart Jackson and IIya Trakhtenberg presented insights from their book 'Predictable Winners' at the 2025 Healthcare Operator Summit.
  • McKinsey & CompanyminorStrategic or Co-development PartnerDr. Jeet Guram from McKinsey led a session on 'State of the Healthcare Market and PE Value Creation' at the 2025 Operator Summit.
  • BairdminorStrategic or Co-development PartnerBen Port and Jason Porter from Baird's Global Healthcare Investment Banking Group led discussions on M&A environment in healthcare at the 2025 Operator Summit.
  • Morgan StanleyminorStrategic or Co-development PartnerPeter Harrison from Morgan Stanley led discussions on M&A and capital markets environment in MedTech at the 2025 Operator Summit.
  • Reveal HealthTechminorStrategic or Co-development PartnerSanchit Mullick and Andrew Bravo from Reveal HealthTech led a session on leveraging AI in portfolio company value creation.
  • ghSMART & CompanyminorStrategic or Co-development PartnerMichael Haugen from ghSMART presented the ghSMART A Method for hiring top talent at the 2025 Operator Summit dinner.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

RC Capital competitors and assessment

Company assessment

Direct peers

  • Webster Equity Partners: Webster Equity Partners is a healthcare-focused growth and buyout firm investing in the lower middle market, with similar deal-size profile and sector emphasis on healthcare services and products — directly comparable to RC Capital's strategy.
  • Thyra Capital: Thyra Capital is a healthcare-focused private equity firm targeting growth-stage and lower middle market healthcare companies, overlapping closely with RC Capital's Medical Devices, Healthcare Services, and HCIT focus areas.
  • Shore Capital Partners: Shore Capital Partners is a lower middle market private equity firm with a dedicated healthcare practice, investing equity in growth-stage healthcare companies — a close strategic and structural analog to RC Capital.
  • Health Velocity Capital: Health Velocity Capital is a healthcare-focused growth equity and venture firm investing across healthcare services, HCIT, and medical devices, making it a closely comparable growth-stage specialist peer.
  • AlerisLife (legacy Watermark Capital / Cressey & Company): Cressey & Company is a healthcare-focused PE firm based in Chicago investing in growth-stage healthcare services and technology businesses, similar in strategy and scale to RC Capital.
  • Avista Capital Partners: Avista Capital Partners is a healthcare-focused private equity firm investing across healthcare services, pharmaceuticals, and medical devices — a closely comparable sector-specialist peer for benchmarking strategy and portfolio overlap.

Broad incumbents

  • Welsh, Carson, Anderson & Stowe (WCAS): WCAS is a large, established healthcare-focused private equity firm with a much broader AUM base but a comparable healthcare services and HCIT investment lens, making it an incumbent reference point for sector-specialist PE.
  • New Mountain Capital: New Mountain Capital is a large investment firm with a strong healthcare services and healthcare IT franchise, representing a larger incumbent that competes for many of the same assets RC Capital targets.
  • Genstar Capital: Genstar Capital is a diversified PE firm with a meaningful healthcare growth and buyout practice, including medical device and services investing — a relevant broader incumbent in the healthcare lower middle and middle market.
  • TPG Capital: TPG operates large healthcare-dedicated funds (TPG Healthcare) investing across services, devices, and life sciences — an incumbent mega-fund whose activities increasingly extend into RC Capital's addressable market.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

RC Capital social profiles

Digital presence

RC Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RC Capital leadership team

Management profile

Number of profiles

Profiles22 records

RC Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RC Capital M&A and investment

M&A and investment

M&A1 record

Investments117 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RC Capital

What does RC Capital do?

RC Capital is a healthcare-focused growth equity firm that invests in lower middle market companies across Medical Devices, Healthcare Services, and Healthcare IT. The firm acquires majority or significant equity stakes, then partners with management to drive transformational growth through operational support, strategic guidance, and network access, ultimately realizing returns through M&A exits or recapitalizations.

Is RC Capital a public or private company?

RC Capital is a private company. It is classified as management employee owned and is currently operating.

When was RC Capital founded?

RC Capital was founded in 1994. It employs 51 to 100 people.

Where is RC Capital based?

RC Capital is headquartered in Cincinnati, United States, in the North America region.

How does RC Capital make money?

One revenue line is on record: portfolio Company Investment Returns.

Who are RC Capital's main competitors?

Direct peers on record are Webster Equity Partners, Thyra Capital, Shore Capital Partners, Health Velocity Capital, AlerisLife (legacy Watermark Capital / Cressey & Company) and Avista Capital Partners. Broad incumbents are Welsh, Carson, Anderson & Stowe (WCAS), New Mountain Capital, Genstar Capital and TPG Capital.

Does RC Capital have an API?

No public API is recorded for RC Capital.

What industry is RC Capital in?

RC Capital's product category is Healthcare Growth Equity (Private Equity). Its primary akta.pro industry code is FSANACAD, Business Services (B2B) Growth Equity, with a secondary code of FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Captive Radiology: Growth Investment From RC Capital To Accelerate Diagnostic Imaging ExpansionCaptive Radiology, a provider of turnkey diagnostic imaging solutions founded in 2003, announced a strategic growth investment from healthcare-focused investment firm RC Capital. The partnership is expected to accelerate Captive Radiology's national expansion, enhance service capabilities, and expand access to diagnostic imaging and theranostic services for healthcare providers and patients, with the company recently expanding into PET-CT imaging for prostate cancer detection. RC Capital, which specializes in healthcare services and medical devices, stated that the investment aligns with its strategy of partnering with healthcare companies focused on improving care delivery and patient outcomes.citybizCaptive Radiology Secures RC Capital Investment to Expand Imaging and Theranostics PlatformCaptive Radiology, a diagnostic imaging provider founded in 2003, has secured a growth investment from healthcare-focused firm RC Capital to expand its imaging and theranostics platform nationally. The company operates more than 30 imaging partnerships across nearly 20 states, offering hospitals and physician groups turnkey imaging infrastructure and operational services. The investment reflects growing investor interest in precision diagnostics, particularly in PET-CT imaging and theranostics, as healthcare delivery shifts toward outpatient care models and earlier disease detection.FinSMEsCaptive Radiology Receives Growth InvestmentCaptive Radiology, a North Canton, OH-based diagnostic imaging provider, received a strategic growth investment from RC Capital, with the amount undisclosed. The company will use the funds to accelerate expansion and enhance service capabilities. It operates over 30 imaging partnerships across nearly 20 states.CaptiveradiologyCaptive Radiology Announces Partnership with RC CapitalCaptive Radiology announced a strategic partnership with RC Capital, a healthcare-focused private equity firm, to fund growth and expand imaging services. The partnership will enable launching new Captive programs in more markets and enhancing technology and operational support. Existing leadership and partner relationships remain unchanged.DakotaTop Ten Private Equity Firms in CincinnatiDakota Research published an analysis identifying the top ten private equity firms operating in the Cincinnati metropolitan area, highlighting their distinct investment strategies and market focus. The report details how these firms, including RC Capital, Timber Bay Partners, and Fireroad Ventures, are driving deal-making and market transformation across sectors such as healthcare, manufacturing, and technology. This overview serves to inform investment professionals about key regional players and their operational approaches.PR NewswireTUSK Practice Sales Advises Endodontic Specialists in its sale to Endodontic Practice Partners, a portfolio company of RC CapitalTUSK Practice Sales advised Endodontic Specialists in their sale to Endodontic Practice Partners, a portfolio company of RC Capital, on March 5, 2024. The transaction aimed to maximize valuation and support growth for Endodontic Specialists, which has operated in Lansing, Michigan for over 30 years. This partnership is expected to enhance the capabilities and reach of Endodontic Specialists in the endodontic care market.ThedealRC Capital Seals Cardiology DealHealthcare-focused growth equity firm River Cities Capital Funds (RC Capital) has partnered with James River Cardiology to form Aligned Cardiovascular Partners, a new entity in the cardiology sector. Terms of the transaction were not disclosed. The deal was advised by Provident Healthcare Partners for James River and McDermott Will & Emery for RC Capital, with the announcement made on May 31.PR NewswireRC Capital Completes Growth Equity Investment in James River Cardiology to Form Aligned Cardiovascular PartnersRC Capital has completed a growth equity investment in James River Cardiology, resulting in the formation of a new entity named Aligned Cardiovascular Partners. Rob Jardeleza will serve as CEO of the newly formed organization, while executives from RC Capital will join its Board of Directors.FinSMEsNico Raises $12.5M in FundingNico Corporation, an Indianapolis-based medical device company, completed a $12.5 million capital raise led by RC Capital with participation from existing investors. The funds will be used to scale the business and leverage progress on its adaptive clinical trial for intracerebral hemorrhage and a new partnership in functional precision oncology.PR NewswireNICO Raises $12.5 Million in Oversubscribed Investment RoundNICO Corporation completed a $12.5 million oversubscribed capital raise led by RC Capital to scale its business and support clinical trials for intracerebral hemorrhage and functional precision oncology treatments. The funding follows 25 percent revenue growth in 2021 and aims to capitalize on the industry's shift toward minimally invasive neurosurgery approaches.